An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score

被引:453
|
作者
Stewart, WF
Lipton, RB
Whyte, J
Dowson, A
Kolodner, K
Liberman, JN
Sawyer, J
机构
[1] Innovat Med Res, Towson, MD USA
[2] Johns Hopkins Sch Publ Hlth, Baltimore, MD USA
[3] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10467 USA
[4] Albert Einstein Coll Med, Dept Epidemiol, Bronx, NY 10467 USA
[5] Albert Einstein Coll Med, Dept Social Med, Bronx, NY 10467 USA
[6] Zeneca Pharmaceut, Alderley Pk, England
[7] Kings Coll Hosp London, London, England
关键词
migraine disability; headache pain severity;
D O I
10.1212/WNL.53.5.988
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: The Migraine Disability Assessment (MIDAS) instrument is a five-item questionnaire developed to measure headache-related disability and improve doctor-patient communication about the functional consequences of migraine. Objectives: To examine the test-retest reliability and internal consistency of the five items and of the overall MIDAS score in population-based samples of migraine sufferers in two countries and to compare consistency across countries. Methods: Using a clinically validated telephone interview, population-based samples of migraine-headache sufferers were identified in the United States (Baltimore, MD) and the United Kingdom (Merton and Sutton, Surrey). Eligible individuals completed the MIDAS questionnaire on two occasions an average of 3 weeks apart. The MIDAS score is derived from five questions about missed time from work and household work (one question each about missed days and days with at least 50% reduced productivity) and missed days of nonwork activities. Results: A total of 97 migraine-headache sufferers from the United States and 100 from the United Kingdom completed the MIDAS questionnaire twice. Mean and median item values and overall MIDAS scores were similar between the United States and the United Kingdom. Test-retest Spearman correlations of individual items ranged from 0.46 to 0.78, No significant differences in item-specific correlations were observed between the United States and United Kingdom. The test-retest Pearson correlation of the MIDAS score (i.e., sum of lost days and reduced-effectiveness days in each domain) was 0.80 in the United States and 0.83 in the United Kingdom. The Cronbach alpha, a measure of internal consistency, was 0.76 in the United States and 0.73 in the United Kingdom. Conclusions: This is the first international population-based study to assess the reliability of a disability-related illness severity score for migraine. The reliability and internal consistency of the Migraine Disability Assessment score are similar to that of a previous questionnaire (Headache Impact Questionnaire), However, the Migraine Disability Assessment score requires fewer questions, is easier to score, and provides intuitively meaningful information on lost days of activity in three domains.
引用
收藏
页码:988 / 994
页数:7
相关论文
共 50 条
  • [1] Cost of migraine stratified by migraine disability assessment (MIDAS) score in the workplace
    Paramore, L. C.
    Page, M.
    Doshi, D.
    Rupnow, M.
    [J]. HEADACHE, 2007, 47 (05): : 778 - 779
  • [2] Reliability and validity of the Japanese Migraine Disability Assessment (MIDAS) Questionnaire
    Iigaya, M
    Sakai, F
    Kolodner, KB
    Lipton, RB
    Stewart, WF
    [J]. HEADACHE, 2003, 43 (04): : 343 - 352
  • [3] The migraine disability assessment (MIDAS) questionnaire: reliability of the French version
    Lanteri-Minet, M
    Alchaar, H
    Besson, G
    Brudon, F
    Donnet, A
    Giraud, P
    Valance, J
    Bille-Turc, F
    Gaustaut, JL
    [J]. CEPHALALGIA, 2003, 23 (07) : 750 - 750
  • [4] Validity and reliability of the Turkish Migraine Disability Assessment (MIDAS) questionnaire
    Ertas, M
    Siva, A
    Dalkara, T
    Uzuner, N
    Dora, B
    Inan, L
    Idiman, F
    Sarica, Y
    Selçuki, D
    Sirin, H
    Oguzhanoglu, A
    Irkeç, C
    Özmenoglu, M
    Özbenli, T
    Öztürk, M
    Saip, S
    Neyal, M
    Zarifoglu, M
    [J]. HEADACHE, 2004, 44 (08): : 786 - 793
  • [5] Reliability and Validity of the Greek Migraine Disability Assessment (MIDAS) Questionnaire
    Oikonomidi T.
    Vikelis M.
    Artemiadis A.
    Chrousos G.P.
    Darviri C.
    [J]. PharmacoEconomics - Open, 2018, 2 (1) : 77 - 85
  • [6] Validity and reliability of Migraine Disability Assessment (MIDAS) Questionnaire in Turkish patients with migraine
    Gedikoglu, U
    Ücler, S
    Coskun, O
    Tunc, T
    Emre, U
    Yildiz, H
    Inan, L
    [J]. CEPHALALGIA, 2003, 23 (07) : 757 - 757
  • [7] The Migraine Disability Assessment (MIDAS) questionnaire: translation and reliability of the Italian version
    D'Amico, D
    Mosconi, P
    Genco, S
    Usai, S
    Prudenzano, AMP
    Grazzi, L
    Leone, M
    Puca, FM
    Bussone, G
    [J]. CEPHALALGIA, 2001, 21 (10) : 947 - 952
  • [8] Validity and reliability of Turkish translation of Migraine Disability Assessment (MIDAS) questionnaire in patients with migraine
    Gedikoglu, U
    Coskun, O
    Inan, LE
    Ucler, S
    Tunc, T
    Emre, U
    [J]. CEPHALALGIA, 2005, 25 (06) : 452 - 456
  • [9] Development and testing of the Migraine Disability Assessment (MIDAS) Questionnaire to assess headache-related disability
    Stewart, WF
    Lipton, RB
    Dowson, AJ
    Sawyer, J
    [J]. NEUROLOGY, 2001, 56 (06) : S20 - S28
  • [10] Minimal important change and responsiveness of the Migraine Disability Assessment Score (MIDAS) questionnaire
    Carvalho, Gabriela F.
    Luedtke, Kerstin
    Braun, Tobias
    [J]. JOURNAL OF HEADACHE AND PAIN, 2021, 22 (01):